Search Results 91-100 of 16562 for Cirrhosis
This study is to evaluate the safety and efficacy of simtuzumab (GS-6624) in adults with compensated cirrhosis due to Non-Alcoholic Steatohepatitis (NASH).
... cirrhosis. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
In the following model, short-term survival probability of a patient with primary biliary cholangitis is estimated based on repeated observation.
In patients without cirrhosis, MRE can guide disease surveillance and timing of longitudinal, noninvasive monitoring in NAFLD . In patients with cirrhosis, MRE ...
... cirrhosis. While invasive liver biopsy was required to detect cirrhosis, the development of magnetic resonance elastography (MRE) has revolutionized our ...
... (cirrhosis) of the liver undergoing surgery. Erlotinib hydrochloride may help to inhibit the development of fibrous tissue and prevent liver cancer from ...
Cirrhosis; Hepatitis caused by a virus — including hepatitis A, B and C — or caused by infectious mononucleosis; Nonalcoholic fatty liver disease; Alcoholic ...
If you have cirrhosis, your health care provider typically screens you for esophageal varices when you're diagnosed. How often you'll have screening tests ...
GLE/PIB 8 wks a-TE with PEG/RBV, no cirrhosis 8 wks b-Cirrhosis and TE with non-NS5A DAA 12 wks c-ESRD 12 wks d-Post-LT without cirrhosis and KT 12 wks.
Primary Biliary Cirrhosis (PBC) is a serious, life--threatening, bile acid related liver disease of unknown cause. Without treatment, it frequently progresses ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.